Abstract
Elevated glycolytic metabolism is essential for CD8+ Tcell antitumor function, but cell-intrinsic factors modulating this process remain elusive. In this issue, Hu etal. (2019) show that the lipid kinase acylglycerol kinase (AGK) promotes the glycolytic and functional fitness of CD8+ Tcells by inactivating PTEN and boosting mTOR activity, thereby promoting antitumor activity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
